Oncimmune Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Martin Gouldstone
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 3.4yrs |
Recent management updates
CEO
Martin Gouldstone (57 yo)
less than a year
Tenure
Mr. Martin John Gouldstone is Chief Executive Officer and Director of Oncimmune Holdings plc from August 1, 2023. He serves as Non-Executive Director of ValiRx Plc since February 2024. He is Independent No...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| Finance Director | less than a year | no data | no data | |
| COO, General Counsel & Company Secretary | 4yrs | no data | 0.0022% £ 433.0 | |
| Chief Scientific Officer | 4.5yrs | no data | no data | |
| Head of Investor Relations | 4.8yrs | no data | no data | |
| Chief Commercial Officer of Asia | 7.6yrs | no data | no data |
4.3yrs
Average Tenure
Experienced Management: ONC's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| Senior Independent Non-Executive Director | less than a year | no data | no data | |
| Non-executive Chairman | 1.8yrs | UK£17.00k | 0.075% £ 14.6k | |
| Independent Non-Executive Director | 1.3yrs | no data | 1.55% £ 301.3k | |
| Member of Scientific Board | 5yrs | no data | no data | |
| Member of Scientific Board | 5.3yrs | no data | no data | |
| Member of Scientific Board | 5.3yrs | no data | no data | |
| Member of Scientific Board | 5.3yrs | no data | no data |
3.4yrs
Average Tenure
55yo
Average Age
Experienced Board: ONC's board of directors are considered experienced (3.4 years average tenure).